3PC-063 Galenic preparation of 40% dextrose gel: new approach to management of neonatal hypoglycaemia. (March 2019)

• Record Type: Journal Article
• Authors: Rivano, M; Veneziano, C; Longobardo, G; Albrecht, M
• Is Part Of: European journal of hospital pharmacy. Volume 26(2019)Supplement 1
• Page Start: A65
• Page End: A65
• Publication Date: 2019-03
• Subjects: Pharmacy -- Periodicals; Hospital pharmacies -- Periodicals; 615.1
• DOI: 10.1136/ejhpharm-2019-eahpconf.144
• Languages: English
• ISSNs: 2047-9956

Abstract

Abstract : Background: Neonatal hypoglycaemia is a condition in which the amount of blood glucose is lower than <45 mg/dl. Transiently low blood glucose levels are physiologic and occur during the establishment of postnatal glucose homeostasis. Nevertheless, severe prolonged hypoglycaemia is associated with brain injury and poor neurodevelopmental outcome. Preterm, small for gestational age infants, infants of diabetic mothers and large for gestational age infants are at high risk. Diagnosis is suspected empirically and is confirmed by glucose testing. There are several treatment options available for the management of neonatal hypoglycaemia: breast-milk, infant formula, intravenous (IV) or oral dextrose therapy. The neonatal care unit asked the pharmacy for collaboration in the galenic preparation of 40% dextrose gel for the treatment of neonatal hypoglycaemia. Purpose: The objective of this work is the preparation of a galenic formulation in order to develop a safe and effective treatment for the management of hypoglycaemia in newborns. Material and methods: A systematic literature review concerning dextrose gel preparation was conducted and the pharmacy service developed a procedure for the galenic formulation. The preparation consists of a glucose gel solution and carboxymethylcellulose. The obtained gel was divided into sterile snteral feeding syringes with a female connector. Results: In our hospital, in the first semester of 2018, 30 newborn infants had hypoglicaemia. Fifteen received intravenous dextrose therapy and six babies were given breastmilk or formula by syringe. Nine infants were treated with dextrose gel 5 ml/Kg massaged into the buccal mucosa. Only one patient with severe hypoglicaemia (26 mg/dl) received additional intravenous dextrose. Conclusion: Dextrose gel formulation prepared by the pharmacy service responded to the needs of the neonatal care unit. This preparation has been recommended for the management of neonatal hypoglycaemia and reduced the admission to the newborn intensive care unit for intravenous glucose. Our findings show that treatment with 40% dextrose gel is effective in the management of hypoglycaemia and does not adversely affect breastfeeding. Reference and/or acknowledgements: Harris DL, Weston PJ, Signal M, et al. Dextrose gel for neonatal hypoglycaemia (the Sugar Babies Study): a randomised, double-blind, placebo-controlled trial. Lancet 2013;382:2077–83. No conflict of interest.